BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Research Seminar Series—Neuropilin-2 Promotes Oral Carcinogenesis by Stimulating Tumor Growth and Angiogenesis While Suppressing Tumor Immunity
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1597386_0
SUMMARY:Research Seminar Series—Neuropilin-2 Promotes Oral Carcinogenesis by Stimulating Tumor Growth and Angiogenesis While Suppressing Tumor Immunity
DESCRIPTION:<p>Join us for the next Research Seminar Series featuring Dr. Diane Bielenberg, whose laboratory investigates how neuropilin receptors influence oral cancer, immune surveillance, blood vessel formation, inflammation, and other disease processes. Learn how this research is advancing the understanding of cancer and other complex conditions.&nbsp;</p><p><em>Lunch will be provided.</em></p><hr><drupal-media data-entity-type="media" data-entity-uuid="63880102-3751-4e2b-b499-d25599f4293f" data-view-mode="hwp_small" data-align="left">&nbsp;</drupal-media><h2>About the speaker</h2><p>Dr. Diane Bielenberg is an assistant professor in the Department of Surgery at Harvard Medical School and a principal investigator in the Vascular Biology Program at Boston Children’s Hospital. Her laboratory studies the role of neuropilin receptors in neovascularization, lymphatic drainage, smooth muscle tone, inflammation, and carcinogenesis. This translational research has implications for hypertension, lymphedema, smooth muscle motility disorders, obesity, cancer, and chronic inflammation.</p>
LOCATION:REB 109 and Zoom
STATUS:CONFIRMED
DTSTART:20260923T160000Z
DTEND:20260923T170000Z
END:VEVENT
END:VCALENDAR